Senseonics closes $1.1M acquisition of U.S. Eversense assets from Ascensia

Senseonics Holdings, Inc.

U.S. asset purchase closed Jan 1, 2026; cash consideration ~$1.1M for inventory, licenses, and leases.
European asset purchases (Italy, Germany, Spain, Sweden) expected to close by June 30, 2026, subject to local agreements.
Amended collaboration agreement gives Senseonics 100% of European Eversense revenues from Jan 1; Ascensia's U.S. rights terminated.
Director Koichiro Sato (PHC Holdings) resigned from board effective Dec 31, 2025; PHC retains designation right but won't currently exercise.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Senseonics Holdings, Inc. amended Amended and Restated Collaboration and Commercialization Agreement with Ascensia Diabetes Care Holdings AG (effective 2025-12-31).

Action: amendment
Agreement: collaboration
Counterparty: Ascensia Diabetes Care Holdings AG
Effective: 2025-12-31

Exact text from the filing

In connection with entering into the Master Asset Purchase Agreement, Senseonics Inc. and the Seller entered into an Amended and Restated Collaboration and Commercialization Agreement (the “ A&R Collaboration Agreement ”) on the Execution Date, which amended and restated that certain Collaboration and Commercialization Agreement, dated August 9, 2020, between Senseonics Inc. and the Seller, as amended to date (the “ Existing Agreement ”).

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Senseonics Holdings, Inc. entered into Master Asset Purchase Agreement with Ascensia Diabetes Care Holdings AG valued at approximately $1.1 million (effective 2025-12-31).

Action: entry
Agreement: asset purchase
Counterparty: Ascensia Diabetes Care Holdings AG
Value: approximately $1.1 million
Effective: 2025-12-31

Exact text from the filing

On December 31, 2025 (the “ Execution Date ”), Senseonics Holdings, Inc. (the “ Company ”), Senseonics, Incorporated, a wholly-owned subsidiary of the Company (“ Senseonics Inc. ” and together with the Company, the “ Purchaser Parties ”) and Ascensia Diabetes Care Holdings AG (the “ Seller ”) entered into a master asset purchase agreement (the “ Master Asset Purchase Agreement ”), pursuant to which, among other things, the Purchaser Parties agreed to acquire Seller’s and as applicable, Seller’s affiliates’, right, title and interest in and to certain assets related Seller’s marketing, selling and distribution of the Eversense® product in the United States

View on SEC.gov

299 material agreements filed in the last 30 days. Browse all material agreements →

Senseonics Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-26-000056

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.